Hisamitsu Pharmaceutical Co., Inc.
HTSUF · OTC
2/28/2025 | 2/28/2024 | 2/28/2023 | 2/28/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $115 | $112 | $122 | $129 |
| Short-Term Investments | $15 | $13 | $15 | $13 |
| Receivables | $47 | $43 | $40 | $38 |
| Inventory | $22 | $21 | $19 | $16 |
| Other Curr. Assets | $5 | $5 | $4 | $3 |
| Total Curr. Assets | $204 | $194 | $199 | $200 |
| Property Plant & Equip (Net) | $60 | $49 | $43 | $39 |
| Goodwill | $1 | $1 | $0 | $0 |
| Intangibles | $5 | $5 | $1 | $1 |
| Long-Term Investments | $71 | $77 | $46 | $39 |
| Tax Assets | $2 | $0 | $1 | $1 |
| Other NC Assets | -$0 | $2 | $23 | $22 |
| Total NC Assets | $139 | $135 | $115 | $103 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $343 | $329 | $314 | $303 |
| Liabilities | – | – | – | – |
| Payables | $10 | $10 | $15 | $13 |
| Short-Term Debt | $1 | $1 | $1 | $1 |
| Tax Payable | $4 | $2 | $2 | $3 |
| Deferred Revenue | $0 | $5 | $16 | $11 |
| Other Curr. Liab. | $32 | $28 | $8 | $4 |
| Total Curr. Liab. | $47 | $46 | $43 | $32 |
| LT Debt | $2 | $1 | $1 | $1 |
| Deferred Rev, NC | $0 | $1 | $8 | $8 |
| Deferred Tax Liab, NC | $4 | $5 | $2 | $4 |
| Other NC Liab. | $10 | $11 | $2 | $2 |
| Total NC Liab. | $16 | $16 | $13 | $16 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $1 | $1 | $1 |
| Total Liabilities | $64 | $62 | $56 | $48 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $8 | $8 | $8 | $8 |
| Retained Earnings | $258 | $243 | $236 | $236 |
| AOCI | $0 | $48 | $37 | $26 |
| Other Equity | $10 | -$35 | -$25 | -$17 |
| Total Equity | $277 | $265 | $256 | $253 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $3 | $2 | $2 | $2 |
| Total Liab. & Tot. Equity | $343 | $329 | $314 | $303 |
| Net Debt | -$111 | -$110 | -$120 | -$127 |